NeuMoDx Molecular, a QIAGEN company Email Format
Medical Equipment ManufacturingMichigan, United States51-200 Employees
NeuMoDx Molecular, a QIAGEN company based in Ann Arbor, Michigan, develops automated molecular diagnostic platforms designed to streamline the full test workflow from sample to result. Its NeuMoDx 288 and 96 systems use integrated microfluidics and robotics to run multiple samples with real-time PCR, supported by proprietary reagent technology. The systems aim to boost throughput and efficiency by reducing waste associated with reconstituted lyophilized reagents. Its customer base includes central clinical laboratories seeking scalable, automated molecular diagnostics. The company has FDA 510(k) clearance for its GBS assay, continues development of infectious-disease tests, and offers general reagents and consumables to support laboratory-developed tests on its platforms.